Scientists at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center developed BiliSeq, a molecular test that detected bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of the patient’s diagnosis.
Molecular Test Doubles Detection of Bile Duct Cancer
